The customer is building the world’s most powerful metabolomics platform, which accelerates the discovery, development, and manufacturing of biologics and gene therapies. The mission is to democratize metabolomics and catalyze its widespread adoption and integration into the life sciences. The platform combines mass spectrometry with advanced AI to systematize, scale, and accelerate metabolomics workflows.
The project is to re-architecture of legacy R&D software tools as the client prepare the digital platform for commercialization as a unified, microservices-based cloud platform. This is a unique opportunity to contribute to the delivery of a first-of-its-kind digital metabolomics platform, which will advance scientific research and discovery.